Elkem's Helge Aasen to step down as CEO, nominated as board chairman

Key highlights
  • Proposed board changes take effect upon completion of the sale of the majority of Elkem's Silicones division to Bluestar.
  • Helge Aasen will step down as CEO and is nominated to become chairman of Elkem's board.
  • Aasen will remain CEO until a successor has been appointed and is in place.
  • Annual General Meeting scheduled for 30 April 2026.

Board nominations

The nomination committee has proposed shareholder-elected board members to take effect upon completion of the sale of the majority of Elkem’s Silicones division to Bluestar; Helge Aasen is nominated to become chairman when he steps down as CEO.

CEO transition

Aasen will step down from the CEO role but will remain in position to ensure a smooth transition until a successor is appointed and in place.

Annual General Meeting

The Annual General Meeting is scheduled for 30 April 2026.

Source: Elkem

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

30 April 2026
Elkem completes sale of Silicones division to Bluestar and redeems Bluestar shares

Registered share capital is NOK 1,505,514,210 (301,102,842 shares, NOK 5 par). Board and Nomination Committee changes took effect; seller no longer represented.

11 March 2026
Elkem Restructures and Cuts Costs to Boost Competitiveness

Elkem introduces a new structure, reduces workforce by 300, and cuts costs by NOK 1.9 billion to enhance profitability amid market challenges.

13 February 2026
Elkem to Sell Majority of Silicones Division to Bluestar

Elkem to transfer Silicones division to Bluestar, settling through share redemption. Transaction awaits shareholder and regulatory approvals, expected to close by May 2026.